Feedback
The current prices are delayed. Login to see live prices.

GlaxoSmithKline Pharmaceuticals Ltd.

(GLAXO)

20123456789,801234567898012345678900123456789.3012345678950123456789
+43.45 (+1.53%)
Updated 15:58 28/03 IST
Add
Previous Close: 2836.9
Today's low
₹2,809.40
Today's high
₹2,899.95
52 week low
₹1,842.05
52 week high
₹3,088
Open
₹2,836.9
Prev Close
₹2,836.9
Volume (shares)
108,168
Total Trading Value
30.69 Cr

Technicals

SMA
Value
Signal
12-SMA
2,399.55
Bullish
20-SMA
2,268.02
Bullish
50-SMA
2,195.93
Bullish
100-SMA
2,356.42
Bullish
200-SMA
2,512.29
Bullish

Discussions

  •  Mar 24 3:58 AM
Weekly chart.....read more

2

1
  •  Mar 9 3:47 PM
💠💠Weekly Series 💠💠
📉These are some swing analyses. 📉...read more

1

3

  •  Feb 20 3:31 AM
GLAXO Price action analysis
Based on the recent price action, GlaxoSmithKline Pharma...read more

4

1
  •  Feb 14 11:18 PM
  •  Feb 19 2:01 PM
💫 #GLAXO PERFECT REVERSAL CANDIDATE 💫
TARGET - 3000 💹...read more

2

Load More Posts

Frequently Asked Questions (FAQs)

What is the Share Price of GlaxoSmithKline Pharmaceuticals Ltd. ?

The share prices are volatile and fluctuate throughout the trading hours. The share price of GlaxoSmithKline Pharmaceuticals Ltd. is Rs 2836.9 as of 28 March 2025.

What is the Market Capitalization of GlaxoSmithKline Pharmaceuticals Ltd. ?

The current market cap of GlaxoSmithKline Pharmaceuticals Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.

What are the PE and PB ratios of GlaxoSmithKline Pharmaceuticals Ltd.?

GlaxoSmithKline Pharmaceuticals Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.

What is the 52-week high/low of GlaxoSmithKline Pharmaceuticals Ltd.?

The 52-week high of GlaxoSmithKline Pharmaceuticals Ltd. is Rs 3088 and the 52-week low is Rs 1842.05
Hero Img
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
DisclaimerPrivacy
FrontPage © 2025